Sources | Names Used |
---|---|
CTRPv2 | BRD-K11533227 |
PharmacoGx | BRD-K11533227 |
Database | Identifier |
---|---|
Smiles: | -666 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PFDN1 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
mRNA | NMT2 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
mRNA | IDO2 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
mRNA | ILK | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
mRNA | RGS20 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
mRNA | MLLT11 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
mRNA | NPIPB7 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
mRNA | MAML2 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
mRNA | RP11-195F19.29 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
mRNA | ATXN7L3B | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |